pentobarbital will lower the extent or impact of isavuconazonium sulfate by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. pentobarbital will minimize the level or influence of conivaptan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.